scholarly article | Q13442814 |
P50 | author | Kamesh Ayasolla | Q80255734 |
P2093 | author name string | Inderjit Singh | |
Avtar K Singh | |||
P2860 | cites work | The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes | Q24290792 |
The AMP-activated protein kinase--fuel gauge of the mammalian cell? | Q24315074 | ||
The complex life of simple sphingolipids | Q24537161 | ||
Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages | Q24561388 | ||
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei | Q27860728 | ||
Inflammation and Alzheimer's disease | Q28138617 | ||
AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling | Q28216932 | ||
Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases | Q28239642 | ||
The role of neutral sphingomyelinase produced ceramide in lipopolysaccharide-mediated expression of inducible nitric oxide synthase | Q28566962 | ||
LKB1 is the upstream kinase in the AMP-activated protein kinase cascade | Q28610414 | ||
Antioxidants, oxidative stress, and degenerative neurological disorders | Q33796840 | ||
New anti-inflammatory treatment strategy in Alzheimer's disease | Q33907918 | ||
Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier | Q33951351 | ||
Tyrosine nitration of a synaptic protein synaptophysin contributes to amyloid β-peptide-induced cholinergic dysfunction | Q34196060 | ||
Glutathione metabolism and its implications for health | Q34301684 | ||
Evaluation of selective COX-2 inhibitors for the treatment of Alzheimer's disease | Q34626110 | ||
Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach | Q34727547 | ||
The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis | Q34831062 | ||
Inhibition of lipopolysaccharide‐inducible nitric oxide synthase, TNF‐α and COX‐2 expression by sauchinone effects on I‐κBα phosphorylation, C/EBP and AP‐1 activation | Q35045262 | ||
AMP-activated protein kinase, super metabolic regulator | Q35053000 | ||
Inflammatory processes in Alzheimer's disease | Q35201137 | ||
Immunotherapeutic Approaches to Alzheimer's Disease | Q35573436 | ||
Neuronal structure is altered by amyloid plaques | Q35939250 | ||
Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease | Q36604677 | ||
IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program. | Q38363101 | ||
5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages | Q40560732 | ||
Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1 beta production | Q40580069 | ||
Cyclooxygenase (COX)-2 and COX-1 Potentiate β-Amyloid Peptide Generation through Mechanisms That Involve γ-Secretase Activity | Q40631665 | ||
Beta-amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon -gamma and 'advanced glycation endproducts' in a murine microglia cell line | Q40668554 | ||
Regulation of the forkhead transcription factor FKHR (FOXO1a) by glucose starvation and AICAR, an activator of AMP-activated protein kinase | Q40716878 | ||
AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release. | Q40998382 | ||
Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes | Q41063461 | ||
Regulation of glycogen synthase by glucose and glycogen: a possible role for AMP-activated protein kinase | Q42435111 | ||
Expression of inducible nitric oxide synthase and cyclooxygenase-2 after excitotoxic damage to the immature rat brain | Q42523538 | ||
The highly selective cyclooxygenase-2 inhibitor DFU is neuroprotective when given several hours after transient cerebral ischemia in gerbils. | Q43872416 | ||
Activation of the ERK pathway and atypical protein kinase C isoforms in exercise- and aminoimidazole-4-carboxamide-1-beta-D-riboside (AICAR)-stimulated glucose transport | Q43972679 | ||
AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats | Q44155454 | ||
AMP kinase activation ameliorates insulin resistance induced by free fatty acids in rat skeletal muscle | Q44176909 | ||
Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation | Q44182830 | ||
Neuroprotection of cultured cortical neurons mediated by the cyclooxygenase-2 inhibitor APHS can be reversed by a prostanoid | Q44246554 | ||
Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide | Q44448203 | ||
Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells | Q44468960 | ||
Characterization of the toxic mechanism triggered by Alzheimer's amyloid-beta peptides via p75 neurotrophin receptor in neuronal hybrid cells | Q44556484 | ||
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state | Q44689258 | ||
5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase. | Q44728727 | ||
Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. | Q44728755 | ||
P2X7 receptor modulation of beta-amyloid- and LPS-induced cytokine secretion from human macrophages and microglia. | Q44740842 | ||
Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke | Q44870573 | ||
Regulation of gene expression associated with acute experimental autoimmune encephalomyelitis by Lovastatin | Q44937008 | ||
Inflammatory mediator and beta-amyloid (25-35)-induced ceramide generation and iNOS expression are inhibited by vitamin E. | Q44955933 | ||
Attenuation of ischemia-reperfusion injury in a canine model of autologous renal transplantation | Q45061944 | ||
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors attenuate beta-amyloid-induced microglial inflammatory responses. | Q45221796 | ||
5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis. | Q46561933 | ||
Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases | Q47761333 | ||
Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses | Q48130989 | ||
Neuroprotective effects of acetylsalicylic acid in an animal model of focal brain ischemia. | Q48236809 | ||
Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain | Q48394369 | ||
Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells | Q48587234 | ||
Alterations in behavior, amyloid beta-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer's disease | Q48591979 | ||
PC12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation | Q57270016 | ||
Pro-inflammatory cytokines induce the transcription factors C/EBPbeta and C/EBPdelta in astrocytes | Q61774073 | ||
Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase | Q72210218 | ||
New insights into the neuropathology and cell biology of Alzheimer's disease | Q73723737 | ||
Microglia-mediated nitric oxide cytotoxicity of T cells following amyloid beta-peptide presentation to Th1 cells | Q73827793 | ||
Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein | Q74736370 | ||
Microglia and Astrocytes in Neuro-Aids, Alzheimers Disease, and Multiple Sclerosis | Q91151567 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | astrocyte | Q502961 |
inflammation | Q101991 | ||
P304 | page(s) | 21 | |
P577 | publication date | 2005-09-20 | |
P1433 | published in | Journal of Neuroinflammation | Q15716679 |
P1476 | title | 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) attenuates the expression of LPS- and Abeta peptide-induced inflammatory mediators in astroglia | |
P478 | volume | 2 |
Q39849688 | Acadesine inhibits tissue factor induction and thrombus formation by activating the phosphoinositide 3-kinase/Akt signaling pathway |
Q42176144 | Alternative strategy for Alzheimer's disease: stress response triggers |
Q91542980 | Autophagy induction in the treatment of Alzheimer's disease |
Q34287719 | Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease |
Q47656532 | Combination therapy of lovastatin and AMPK activator improves mitochondrial and peroxisomal functions and clinical disease in EAE model |
Q28579147 | Depolarization-induced differentiation of PC12 cells is mediated by phospholipase D2 through the transcription factor CREB pathway |
Q42827686 | Effects of (-)-epicatechin on molecular modulators of skeletal muscle growth and differentiation. |
Q34546610 | Endurance factors improve hippocampal neurogenesis and spatial memory in mice |
Q44684405 | Ginsenoside Rc modulates Akt/FoxO1 pathways and suppresses oxidative stress |
Q37594838 | Hypoxia Positively Regulates the Expression of pH-Sensing G-Protein-Coupled Receptor OGR1 (GPR68) |
Q50641298 | Matairesinol Suppresses Neuroinflammation and Migration Associated with Src and ERK1/2-NF-κB Pathway in Activating BV2 Microglia. |
Q51533022 | Metformin Attenuates Aβ Pathology Mediated Through Levamisole Sensitive Nicotinic Acetylcholine Receptors in a C. elegans Model of Alzheimer's Disease. |
Q43220591 | Metformin increases phagocytosis and acidifies lysosomal/endosomal compartments in AMPK-dependent manner in rat primary microglia. |
Q30386552 | Mimetics of hormetic agents: stress-resistance triggers |
Q57647180 | Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing |
Q36504523 | Rapamycin-induced modulation of HIV gene transcription attenuates progression of HIVAN. |
Q37988399 | Roles of AMP-activated protein kinase in Alzheimer's disease. |
Q37171172 | The role of AMPK in psychosine mediated effects on oligodendrocytes and astrocytes: implication for Krabbe disease |
Q35924492 | Tubular cell phenotype in HIV-associated nephropathy: role of phospholipid lysophosphatidic acid. |
Search more.